CHIARADONNA, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 11.055
EU - Europa 8.271
AS - Asia 4.951
SA - Sud America 719
Continente sconosciuto - Info sul continente non disponibili 560
AF - Africa 141
OC - Oceania 16
Totale 25.713
Nazione #
US - Stati Uniti d'America 10.483
IT - Italia 2.337
SE - Svezia 2.204
SG - Singapore 1.703
CN - Cina 1.207
DE - Germania 1.052
RU - Federazione Russa 685
VN - Vietnam 573
BR - Brasile 529
HK - Hong Kong 524
CA - Canada 417
PL - Polonia 346
GB - Regno Unito 299
IE - Irlanda 283
FR - Francia 267
IN - India 174
UA - Ucraina 171
FI - Finlandia 150
BD - Bangladesh 135
NL - Olanda 109
KR - Corea 97
TR - Turchia 93
ID - Indonesia 86
AT - Austria 74
AR - Argentina 70
DK - Danimarca 68
JP - Giappone 54
IQ - Iraq 51
ZA - Sudafrica 50
ES - Italia 49
MX - Messico 49
CH - Svizzera 35
BE - Belgio 32
SA - Arabia Saudita 28
EC - Ecuador 27
PH - Filippine 26
PK - Pakistan 26
CO - Colombia 25
IR - Iran 21
UZ - Uzbekistan 21
MA - Marocco 20
CZ - Repubblica Ceca 18
HN - Honduras 18
CR - Costa Rica 17
PT - Portogallo 17
VE - Venezuela 17
LT - Lituania 16
CL - Cile 15
JO - Giordania 14
PY - Paraguay 13
SV - El Salvador 13
TN - Tunisia 13
AU - Australia 12
EG - Egitto 12
JM - Giamaica 12
NI - Nicaragua 12
TW - Taiwan 12
AE - Emirati Arabi Uniti 11
MY - Malesia 11
NP - Nepal 10
PE - Perù 10
DZ - Algeria 9
UY - Uruguay 9
AZ - Azerbaigian 8
GT - Guatemala 8
LU - Lussemburgo 8
AL - Albania 7
KE - Kenya 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
RO - Romania 7
ET - Etiopia 6
GR - Grecia 6
HU - Ungheria 6
LB - Libano 6
OM - Oman 6
TH - Thailandia 6
CW - ???statistics.table.value.countryCode.CW??? 5
GP - Guadalupe 5
KZ - Kazakistan 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
IL - Israele 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EE - Estonia 3
EU - Europa 3
LK - Sri Lanka 3
MN - Mongolia 3
SC - Seychelles 3
SI - Slovenia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
Totale 25.122
Città #
Stockholm 1.882
Ann Arbor 1.229
Ashburn 1.112
Singapore 1.021
Milan 750
San Jose 739
Frankfurt am Main 696
Woodbridge 502
Hong Kong 493
Fairfield 404
Wilmington 342
Chandler 338
Council Bluffs 327
Houston 296
Kraków 280
Dublin 275
Dallas 254
New York 245
Toronto 220
Los Angeles 215
Beijing 205
Santa Clara 202
Jacksonville 173
Seattle 168
Dearborn 167
Ho Chi Minh City 164
Hefei 159
Cambridge 146
Chicago 138
Munich 132
Rome 129
The Dalles 122
Hanoi 119
Buffalo 92
Seoul 88
Princeton 87
Columbus 82
Helsinki 77
Boardman 73
Lauterbourg 70
Jakarta 66
Nanjing 62
Shanghai 62
São Paulo 61
Moscow 53
Vienna 51
North Kansas City 50
Phoenix 50
Dong Ket 49
Guangzhou 45
Warsaw 45
Montreal 43
San Diego 43
Atlanta 42
Brooklyn 42
Lawrence 42
Turin 40
Figino 39
Montréal 38
Naples 38
Bologna 37
Tokyo 37
Denver 35
Orem 35
Altamura 32
Cento 32
Chennai 31
Johannesburg 31
Brussels 29
Lachine 29
Nuremberg 29
Da Nang 28
London 27
Baghdad 25
Nanchang 25
Washington 24
Brescia 23
Poplar 22
Salt Lake City 22
Tianjin 21
Amsterdam 20
Torino 20
Zurich 20
Ankara 19
Boston 19
Florence 19
Zhengzhou 19
Andover 18
Falls Church 18
Manchester 18
Paris 18
Rio de Janeiro 18
Hyderabad 17
Tampa 17
Tashkent 17
Dhaka 16
Kent 16
Philadelphia 16
San Francisco 16
Sacramento 15
Totale 16.104
Nome #
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 2.819
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 821
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 727
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells 579
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3) 542
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 514
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. 508
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation 494
Central metabolism of functionally heterogeneous mesenchymal stromal cells 448
Mitochondria in Focus: Targeting the Cell-Death Mechanism 430
From cancer metabolism to new biomarkers and drug targets 425
Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization 424
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability 397
RAS and PKA pathways in cancer: new insight from transcriptional analysis 392
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 391
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor 375
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells 375
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 372
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 369
Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes 355
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts 353
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 351
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 348
Metabolic reprogramming and dysregulated metabolism: Cause, consequence and/or enabler of environmental carcinogenesis? 345
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response 337
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS 336
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 336
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 330
Cancer Metabolism as a New Real Target in Tumor Therapy 330
New Insights into the Connection between Histone Deacetylases, Cell Metabolism, and Cancer 326
Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes 319
Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-ras transformed fibroblasts 309
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 308
Acquired glucose sensitivity of k-ras transformed fibroblasts 307
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration 304
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 302
Genetic and Molecular Characterization of The Human Osteosarcoma 3AB-OS Cancer Stem Cell Line: A Possible Model For Studying Osteosarcoma Origin and Stemness 300
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 294
Systems biology and the molecular circuits of cancer 290
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation 288
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer 287
Mitochondrial Complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death 281
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 281
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer 279
PKA stimulation protects K-ras transformed cells from apoptosis induced by glucose depletion reactivating mitochondrial function 276
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells 275
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 265
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 265
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 256
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 253
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 251
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 248
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2 244
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 232
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 228
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 219
Glucose shortage dependent apoptosis in transformed cells upon activation of UPR-autophagy pathway 219
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 210
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 207
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism 205
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 201
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 200
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 197
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 192
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 177
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 174
Comparative transcriptional analysis between a K-ras cell model of transformation and the NCI60 human cancer cells collection 166
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 140
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 139
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 136
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 133
High throughput metabolomics analysis in normal and K-Ras transformed murine fibroblasts 133
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 125
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 118
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 111
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 109
Histone glycation: a novel epigenetic target in breast cancer 71
FECH, a novel metabolic target influencing CAR T-cell phenotype and function 40
Totale 25.713
Categoria #
all - tutte 67.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 0 110 87 91 59 43 53 43 101 143
2022/20231.440 157 403 162 156 104 183 11 78 102 6 59 19
2023/2024975 24 38 27 79 100 217 203 44 65 34 23 121
2024/20253.104 176 254 296 141 214 140 255 156 265 447 307 453
2025/202611.137 737 466 768 940 1.139 852 1.225 357 848 2.608 508 689
2026/20272.704 376 455 878 995 0 0 0 0 0 0 0 0
Totale 25.713